Zepp Health Corporation (ZEPP) is a Consumer Electronics company in the Technology sector, currently trading at $14.12. It has a SharesGrow Score of 26/100, indicating a weak investment profile with 0 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of ZEPP = $152.78 (+982% from the current price, the stock appears undervalued). Analyst consensus target is ZEPP = $12 (-15% upside).
Valuation: ZEPP trades at a trailing Price-to-Earnings (P/E) of -0.3 (S&P 500 average ~25).
Financials: revenue is $1.8B, +253.9%/yr average growth. Net income is $281M (loss), growing at -58.6%/yr. Net profit margin is -15.5% (negative). Gross margin is 39.2% (+19.8 pp trend).
Balance sheet: total debt is $1.6B against $1.5B equity (Debt-to-Equity (D/E) ratio 1.06, moderate). Current ratio is 1.02 (adequate). Debt-to-assets is 40.4%. Total assets: $3.9B.
SharesGrow 7-Criteria breakdown: Value 20/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 33/100 (Fail), Moat 48/100 (Partial), Future 10/100 (Fail), Income 10/100 (Fail).
